Search for: "RISING PHARMACEUTICALS, INC." Results 101 - 120 of 462
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Mar 2018, 2:10 pm by Tom Lamb
In closing this article, I will point out that as of today, nearly five years after the actions taken by Novartis Pharmaceuticals Canada Inc., in the US there still has not been any "Dear Doctor" letter nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation similar to what was done in Canada during April 2013. [read post]
11 Feb 2018, 2:35 pm by Kevin LaCroix
  Synergy is not only a life sciences company but it is in SIC Code 2834 (Pharmaceutical Preparations). [read post]
8 Jan 2018, 8:53 am by Schachtman
In the Harkonen case, a pharmaceutical executive was indicted and tried for wire fraud and misbranding. [read post]
2 Jan 2018, 5:08 pm by Kevin LaCroix
  In addition to the federal court merger objection lawsuits, there were a number of other important emerging trends contributing to the increase numbers of securities suit filings during the year, including the rise in the number of event-driven lawsuits; the rash of cryptocurrency-related lawsuits at the end of the year; and the number of data breach-related securities lawsuits. [read post]
8 Dec 2017, 12:45 pm by Tom Lamb
" page of the Limbrel.com website (accessed 12/8/17) which is presented by Primus Pharmaceuticals, Inc.: Limbrel contains flavocoxid, a proprietary blend of natural ingredients from phytochemical food source materials. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
30 Nov 2017, 4:26 am by Dennis Crouch
Prometheus Labs., Inc., 132 S. [read post]
20 Nov 2017, 1:14 pm by Richard T. Kaplar
Virginia Citizens Consumer Council, Inc., 425 U.S. 748, 763 (1976). [read post]
20 Nov 2017, 1:14 pm by Richard T. Kaplar
Virginia Citizens Consumer Council, Inc., 425 U.S. 748, 763 (1976). [read post]
12 Oct 2017, 8:29 am by Dennis Crouch
” Inequitable Conduct and Regeneron Pharmaceuticals, Inc. v. [read post]
25 May 2017, 5:30 pm by Angel Reyes III
Continue reading → The post Diabetic Drug Amputations Caused by Johnson & Johnson on the Rise appeared first on Dallas Auto Accident Attorneys Blog. [read post]
28 Apr 2017, 6:01 am by John Duffy
The first specific legal issue that gave rise to the litigation between Amgen and Sandoz is whether, under the statute, Amgen was entitled to obtain Sandoz’s FDA application to market a biosimilar to Amgen’s drug filgrastim (trade name Neupogen). [read post]